These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33983712)

  • 1. NAD(P)H Quinone Oxidoreductase-1 in Organ and Tumor Tissues: Distinct Activity Levels Observed with a Benzo-rosol-Based Dual-Excitation and Dual-Emission Probe.
    Yang YJ; Dai M; Reo YJ; Song CW; Sarkar S; Ahn KH
    Anal Chem; 2021 May; 93(20):7523-7531. PubMed ID: 33983712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-contrast NIR fluorescent probes for selective detection of NQO1 in breast cancer.
    Liu H; Hu F; Cao Z; Qu Y; Wen H; Wang X; Li W
    Spectrochim Acta A Mol Biomol Spectrosc; 2024 Apr; 311():123898. PubMed ID: 38340443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-ratiometric fluorescence sensing and real-time detection of HOCl and NQO1 using a single fluorescent probe under one-wavelength excitation.
    Yue X; Yang Y; Lan M; Li K; Wang B
    Anal Chim Acta; 2022 Sep; 1224():340242. PubMed ID: 35998994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer.
    Zhang K; Chen D; Ma K; Wu X; Hao H; Jiang S
    J Med Chem; 2018 Aug; 61(16):6983-7003. PubMed ID: 29712428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing Push-Pull Hydroxylphenylpolyenylpyridinium Chromophores as Ratiometric Two-Photon Fluorescent Probes for Cellular and Intravital Imaging of Mitochondrial NQO1.
    Yang YP; Qi FJ; Qian YP; Bao XZ; Zhang HC; Ma B; Dai F; Zhang SX; Zhou B
    Anal Chem; 2021 Feb; 93(4):2385-2393. PubMed ID: 33439630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human dioxin-inducible NAD(P)H: quinone oxidoreductase cDNA-encoded protein expressed in COS-1 cells is identical to diaphorase 4.
    Shaw PM; Reiss A; Adesnik M; Nebert DW; Schembri J; Jaiswal AK
    Eur J Biochem; 1991 Jan; 195(1):171-6. PubMed ID: 1899380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAD(P)H:Quinone Acceptor Oxidoreductase 1 (NQO1) Activatable Salicylamide H
    Roy NJ; Save SN; Sharma VK; Abraham B; Kuttanamkuzhi A; Sharma S; Lahiri M; Talukdar P
    Chemistry; 2023 Sep; 29(51):e202301412. PubMed ID: 37345998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues.
    Belinsky M; Jaiswal AK
    Cancer Metastasis Rev; 1993 Jun; 12(2):103-17. PubMed ID: 8375015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a highly specific NQO1-activated near-infrared fluorescent probe and its application for in vivo tumor imaging.
    Punganuru SR; Madala HR; Arutla V; Zhang R; Srivenugopal KS
    Sci Rep; 2019 Jun; 9(1):8577. PubMed ID: 31189950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity-based small fluorescent probe for NAD(P)H:quinone oxidoreductase 1 (NQO1). Design, synthesis and pharmacological evaluation.
    Bian J; Li X; Xu L; Wang N; Qian X; You Q; Zhang X
    Eur J Med Chem; 2017 Feb; 127():828-839. PubMed ID: 27829520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6.
    Jaiswal AK; Burnett P; Adesnik M; McBride OW
    Biochemistry; 1990 Feb; 29(7):1899-906. PubMed ID: 1691923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a new isogenic cell-xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: evaluation of the activity of RH1.
    Dehn DL; Winski SL; Ross D
    Clin Cancer Res; 2004 May; 10(9):3147-55. PubMed ID: 15131056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An NAD(P)H:Quinone Oxidoreductase 1 Responsive and Self-Immolative Prodrug of 5-Fluorouracil for Safe and Effective Cancer Therapy.
    Zhang X; Li X; Li Z; Wu X; Wu Y; You Q; Zhang X
    Org Lett; 2018 Jun; 20(12):3635-3638. PubMed ID: 29847952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
    Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
    Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of NQO1 responsive fluorescence probe and its application in bio-imaging for cancer diagnosis.
    Yuan Z; Xu M; Wu T; Zhang X; Shen Y; Ernest U; Gui L; Wang F; He Q; Chen H
    Talanta; 2019 Jun; 198():323-329. PubMed ID: 30876568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones.
    Winski SL; Swann E; Hargreaves RH; Dehn DL; Butler J; Moody CJ; Ross D
    Biochem Pharmacol; 2001 Jun; 61(12):1509-16. PubMed ID: 11377380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis.
    Long DJ; Waikel RL; Wang XJ; Perlaky L; Roop DR; Jaiswal AK
    Cancer Res; 2000 Nov; 60(21):5913-5. PubMed ID: 11085502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
    Winski SL; Hargreaves RH; Butler J; Ross D
    Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAD(P)H:quinone oxidoreductase 1 reduces the mutagenicity of DNA caused by NADPH:P450 reductase-activated metabolites of benzo(a)pyrene quinones.
    Joseph P; Jaiswal AK
    Br J Cancer; 1998 Mar; 77(5):709-19. PubMed ID: 9514048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) and cytochrome P450 oxidoreductase (CYP450OR) differentially regulate menadione-mediated alterations in redox status, survival and metabolism in pancreatic β-cells.
    Gray JP; Karandrea S; Burgos DZ; Jaiswal AA; Heart EA
    Toxicol Lett; 2016 Nov; 262():1-11. PubMed ID: 27558805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.